TransCode Therapeutics Inc. Gains 42.38%
Tue, May 07, 2024 at 07:20 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) jumped higher at $1.16, representing a gain of 42.4%. On Tue, May 07, 2024, RNAZ:NASDAQ touched a New 2-Week High of $1.16. The stock got featured on our News Catalysts scanner on Mon, Apr 15, 2024 at 10:51 AM in the 'BIOTECH' category. From Tue, Apr 23, 2024, the stock recorded 80.00% Up Days and 72.73% Green Days
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Golden Sun Education Group Limited (GSUN:NASDAQ), 74.31%
- Nuwellis Inc. (NUWE:NASDAQ), 54.04%
- Graphex Group Limited American Depositary Shares each American Depositary Share representing 20 (GRFX:NYSEMKT), 50%
- Mmtec, Inc. (MTC:NASDAQ), 44.78%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 42.38%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 42.29%
- New York City REIT Inc. Class A (NYC:NYSE), 38.1%
- reAlpha Tech Corp. (AIRE:NASDAQ), 35.43%
- Motorsport Games Inc. (MSGM:NASDAQ), 33.19%
- Design Therapeutics Inc. (DSGN:NASDAQ), 28.49%